Viewing nowCombinationFreetwin Tablet 80/5 mg
Telmisartan Powder 23.9% 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.

MFDS item code 201605802 · Approved 2016.09.30 · Insurance code 653403720
Treatment of essential hypertension not controlled with monotherapy
This medication is used to effectively control the blood pressure of patients with essential hypertension whose blood pressure is not adequately controlled with monotherapy of telmisartan or amlodipine.
The recommended dose is 1 tablet once daily, taken with water, with or without food. It is recommended that the medicine be taken at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (telmisartan or amlodipine) before administering this medicine. However, if blood pressure is not controlled with the individual components as described below, switching directly to this medicine may be considered. - 40/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild to moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older patients: The usual amlodipine dosage is recommended for older patients, but caution should be exercised when increasing the dose (see section ‘3. Patients requiring cautious administration’). In patients aged 75 years and older, amlodipine clearance is reduced; therefore, start treatment at a low dose and increase the dose gradually.
The safety and efficacy of this medicine have not been established in pediatric patients 18 years of age or younger; therefore, its use is not recommended.
This medication can pose serious risks to the fetus during pregnancy, particularly in the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. People with allergies to this drug's main ingredients or similar components, those with biliary obstruction diseases, severe liver impairment, heart problems, etc., should not take this medication. Patients with decreased kidney function or diabetes, as well as nursing mothers, are also advised not to use this medication. Careful use is required for patients with certain heart valve diseases, liver impairment, gastrointestinal diseases, renal artery hypertension, and in the elderly, and caution is needed when used in combination with other blood pressure medications. The most common side effects of this medication include dizziness and swelling in the hands and feet; rarely, fainting or cardiac issues may occur. This medication should not be used during pregnancy, and if pregnancy is confirmed, treatment should be discontinued immediately and switched to a safe alternative. Caution is required when there is a lack of fluids or salt, as low blood pressure may occur; if blood pressure drops too low, appropriate treatment should be sought. Since there is a risk of increased potassium levels in the blood, caution is advised when taking potassium supplements or medications high in potassium. Patients with impaired kidney function should have regular blood tests to monitor kidney function and electrolyte levels. Patients with heart disease or heart failure may see their symptoms worsen while taking this medication. This medication contains sorbitol and is not suitable for patients with fructose intolerance. Diabetics may have an increased risk of cardiovascular diseases while taking this medication, so regular cardiac examinations and evaluations are recommended. Dizziness or drowsiness may occur during treatment, so caution is advised when driving or operating machinery. This medication may interact with other drugs, so especially when taken with digoxin, lithium, warfarin, non-steroidal anti-inflammatory drugs, etc., consultation with a physician or pharmacist is necessary. In the case of overdose, symptoms like low blood pressure, dizziness, or cardiac arrhythmias may appear, and it is important to seek immediate medical attention for appropriate treatment. Safety and efficacy in children have not been sufficiently established, so it is not recommended for them, and dosing in the elderly should start at a lower dose and increase gradually.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a light- and air-protected, sealed container, at room temperature between 1 degree and 30 degrees Celsius. Proper storage will help maintain the medication's efficacy for a longer period.
Biconvex oval double-coated tablet in white and light gray
30 tablets/box [(10 tablets/PTP*3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dongkook Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.